Attached files

file filename
EX-32.2 - EX-32.2 - STERLING CHEMICALS INCh82141exv32w2.htm
EX-32.1 - EX-32.1 - STERLING CHEMICALS INCh82141exv32w1.htm
EX-15.1 - EX-15.1 - STERLING CHEMICALS INCh82141exv15w1.htm
EX-31.2 - EX-31.2 - STERLING CHEMICALS INCh82141exv31w2.htm
EX-10.1 - EX-10.1 - STERLING CHEMICALS INCh82141exv10w1.htm
EX-31.1 - EX-31.1 - STERLING CHEMICALS INCh82141exv31w1.htm
Table of Contents

 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 10-Q
     
þ   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2011
OR
     
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to
Commission File Number 000-50132
 
Sterling Chemicals, Inc.
(Exact name of registrant as specified in its charter)
     
Delaware   76-0502785
(State or other jurisdiction of   (IRS Employer Identification No.)
Incorporation or organization)    
     
333 Clay Street, Suite 3600    
Houston, Texas 77002-4109   (713) 650-3700
(Address of principal executive offices)   (Registrant’s telephone number,
    including area code)
     Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ   No o.
     Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes o   No o.
     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer o Accelerated filer o  Non-accelerated filer o
(Do not check if a smaller reporting company)
Smaller reporting company þ
     Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o   No þ.
     As of April 30, 2011, Sterling Chemicals, Inc. had 2,828,460 shares of common stock outstanding.
 
 

 


Table of Contents

IMPORTANT INFORMATION REGARDING THIS FORM 10-Q
     Unless otherwise indicated, references to “we,” “us,” “our” and “ours” in this Form 10-Q refer collectively to Sterling Chemicals, Inc. and its wholly-owned subsidiaries.
Readers should consider the following information as they review this Form 10-Q:
Forward-Looking Statements
     This report contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the United States Securities Exchange Act of 1934, as amended, or the Exchange Act. Forward-looking statements give our current expectations or forecasts of future events. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Forward-looking statements include, without limitation, any statement that may project, indicate or imply future results, events, performance or achievements, and may contain or be identified by the words “expect,” “intend,” “plan,” “predict,” “anticipate,” “estimate,” “believe,” “should,” “could,” “may,” “might,” “will,” “will be,” “will continue,” “will likely result,” “project,” “forecast,” “budget” and similar expressions. Statements in this report that contain forward-looking statements include, but are not limited to, information concerning our possible or assumed future results of operations. While our management considers these expectations and assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory and other risks, contingencies and uncertainties, most of which are difficult to predict and many of which are beyond our control.
     Other sections of this Form 10-Q and our other filings with the Securities and Exchange Commission, or the SEC, including, without limitation, our Annual Report on Form 10-K for the fiscal year ended December 31, 2010, or our Annual Report, include additional factors that could adversely affect our business, results of operations or financial performance. See “Risk Factors” contained in Item 1A of Part I of our Annual Report. Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements. Forward-looking statements included in this Form 10-Q are made only as of the date of this Form 10-Q and are not guarantees of future performance. Although we believe that the expectations reflected in these forward-looking statements are reasonable, such expectations may prove to be incorrect.
Document Summaries
     Descriptions of documents and agreements contained in this Form 10-Q are provided in summary form only, and such summaries are qualified in their entirety by reference to the actual documents and agreements filed as exhibits to our Annual Report, other periodic reports we file with the SEC or this Form 10-Q.
Access to Filings
     Access to our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, and amendments to those reports, filed with or furnished to the SEC pursuant to Section 13(a) of the Exchange Act, as well as reports filed electronically pursuant to Section 16(a) of the Exchange Act, may be obtained through our website (http://www.sterlingchemicals.com), at no cost, as soon as reasonably practicable after we have electronically filed such material with the SEC. The contents of our website (or the third-party websites accessible through the various hyperlinks) are not, and shall not be deemed to be, incorporated into this Form 10-Q.

1


 

STERLING CHEMICALS, INC.
INDEX
             
        Page
 
  PART I. FINANCIAL INFORMATION        
 
           
  Financial Statements     4  
  Management’s Discussion and Analysis of Financial Condition and Results of Operations     14  
  Controls and Procedures     20  
 
           
 
  PART II. OTHER INFORMATION        
 
           
  Legal Proceedings     20  
  Exhibits     20  
 EX-10.1
 EX-15.1
 EX-31.1
 EX-31.2
 EX-32.1
 EX-32.2

2


Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Board of Directors and Stockholders
Sterling Chemicals, Inc.
     We have reviewed the accompanying condensed consolidated balance sheet of Sterling Chemicals, Inc. and its subsidiaries (the “Company”) as of March 31, 2011, and the related condensed consolidated statements of operations and cash flows for the three-month periods ended March 31, 2011 and 2010. These interim financial statements are the responsibility of the Company’s management.
     We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures to financial data and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.
     Based on our reviews, we are not aware of any material modifications that should be made to the accompanying condensed consolidated financial statements for them to be in conformity with accounting principles generally accepted in the United States of America.
     We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the balance sheet of the Company as of December 31, 2010, and the related statements of operations, stockholders’ equity and cash flows for the year then ended (not presented herein); and in our report dated March 1, 2011, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed balance sheet as of December 31, 2010, is fairly stated, in all material respects, in relation to the balance sheet from which it has been derived.
/s/ GRANT THORNTON LLP
Houston, Texas
May 13, 2011

3


Table of Contents

PART I.
FINANCIAL INFORMATION
Item 1. Financial Statements
STERLING CHEMICALS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(Dollars in Thousands, Except Share Data)
                 
    Three months ended March 31,  
    2011     2010  
 
               
Revenues
  $ 25,951     $ 26,682  
Cost of goods sold
    22,822       23,522  
 
           
Gross profit
    3,129       3,160  
Selling, general and administrative expenses
    3,047       2,894  
Impairment of long-lived assets
          290  
Interest and debt related expenses
    3,126       3,607  
Interest income
    (92 )     (49 )
Other income
    (12,802 )     (76 )
 
           
Income (loss) from continuing operations before income tax
    9,850       (3,506 )
Income tax expense (benefit)
    519       (1,227 )
 
           
Income (loss) from continuing operations
  $ 9,331     $ (2,279 )
Income from discontinued operations, net of tax expense of zero and $1,756, respectively
    2,330       3,262  
 
           
Net income
  $ 11,661     $ 983  
Preferred stock dividends
    4,681       4,455  
 
           
Net income (loss) attributable to common stockholders
  $ 6,980     $ (3,472 )
 
           
 
               
Income (loss) per share of common stock attributable to common stockholders, basic and diluted:
               
Income (loss) from continuing operations
  $ 1.65     $ (2.38 )
Income from discontinued operations, net of tax
    0.82       1.15  
 
           
Basic and diluted income (loss) per share
  $ 2.47     $ (1.23 )
 
           
 
               
Weighted average shares outstanding:
               
Basic and diluted
    2,828,460       2,828,460  
The accompanying notes are an integral part of the condensed consolidated financial statements.

4


Table of Contents

STERLING CHEMICALS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(Dollars in Thousands)
                 
    March 31,     December 31,  
    2011     2010  
ASSETS
               
 
               
Current assets:
               
Cash and cash equivalents
  $ 106,070     $ 121,281  
Short-term investments
          9,000  
Accounts and other receivables, net of allowance of $18 and $18, respectively
    25,786       10,981  
Inventories, net
    3,620       3,756  
Prepaid expenses and other current assets
    1,496       2,424  
Assets of discontinued operations, net
    63       306  
 
           
Total current assets
    137,035       147,748  
 
               
Property, plant and equipment, net
    55,302       55,743  
Other assets, net
    3,303       3,908  
 
           
Total assets
  $ 195,640     $ 207,399  
 
           
 
               
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY IN ASSETS
               
 
               
Current liabilities:
               
Accounts payable
  $ 9,755     $ 8,832  
Accrued liabilities
    15,059       18,850  
Liabilities of discontinued operations
    12,382       12,382  
 
           
Total current liabilities
    37,196       40,064  
 
               
Long-term debt
    104,428       119,428  
Long-term liabilities
    40,239       42,678  
Long-term liabilities of discontinued operations
    7,533       10,628  
Commitments and contingencies (Note 4)
               
Redeemable preferred stock
    157,403       152,722  
Stockholders’ deficiency in assets:
               
Common stock, $.01 par value (shares authorized 100,000,000; shares issued and outstanding 2,828,460)
    28       28  
Additional paid-in capital
    84,496       89,153  
Accumulated deficit
    (213,110 )     (224,771 )
Accumulated other comprehensive loss
    (22,573 )     (22,531 )
 
           
Total stockholders’ deficiency in assets
    (151,159 )     (158,121 )
 
           
 
               
Total liabilities and stockholders’ deficiency in assets
  $ 195,640     $ 207,399  
 
           
The accompanying notes are an integral part of the condensed consolidated financial statements.

5


Table of Contents

STERLING CHEMICALS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(Dollars in Thousands)
                 
    Three months ended March 31,  
    2011     2010  
Cash flows from operating activities:
               
Net income
  $ 11,661     $ 983  
Adjustments to reconcile net income to net cash from operating activities:
               
Stock compensation expense
    24       24  
Bad debt expense
          21  
Benefit plan curtailment gain
    (374 )     (115 )
Depreciation and amortization
    2,452       3,041  
Interest amortization
    194       432  
Amortization of deferred revenue
    (3,096 )     (4,280 )
Impairment of long-lived assets
          290  
Gain on disposal of property, plant and equipment
    (74 )     (15 )
Loss (gain) on purchase of Senior Secured Notes
    972       (6 )
Other
    15       13  
Change in assets/liabilities:
               
Accounts and other receivables
    (14,562 )     838  
Inventories
    121       (21 )
Prepaid expenses and other current assets
    928       823  
Other assets
    2       (21 )
Accounts payable
    901       (3,310 )
Accrued liabilities
    (3,791 )     (409 )
Long-term liabilities
    (2,106 )     1,609  
 
           
 
               
Net cash from operating activities
    (6,733 )     (103 )
 
           
 
               
Cash flows from investing activities:
               
Capital expenditures for property, plant and equipment
    (2,304 )     (577 )
Net proceeds from the sale of property, plant and equipment
    389       15  
Redemption of short-term investments
    9,000        
 
           
Net cash from investing activities
    7,085       (562 )
 
           
 
               
Cash flows from financing activities:
               
Purchase of Senior Secured Notes
    (15,563 )     (1,925 )
 
           
Net cash from financing activities
    (15,563 )     (1,925 )
 
           
 
               
Net decrease in cash and cash equivalents
    (15,211 )     (2,590 )
Cash and cash equivalents — beginning of year
    121,281       123,778  
 
           
Cash and cash equivalents — end of period
  $ 106,070     $ 121,188  
 
           
 
               
Supplemental disclosures of cash flow information:
               
Interest paid
  $ 651     $ 129  
Interest income received
    92       49  
Cash received for income taxes
          598  
The accompanying notes are an integral part of the condensed consolidated financial statements.

6


Table of Contents

STERLING CHEMICALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. Basis of Presentation and Accounting Policies
     The accompanying (a) condensed consolidated balance sheet as of December 31, 2010, which was derived from audited financial statements, and (b) the unaudited interim condensed consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, and reflect all adjustments (including normal recurring accruals) which, in our opinion, are considered necessary for the fair presentation of the results for the periods presented. The results of operations and cash flows for the periods presented are not necessarily indicative of the results to be expected for the full year. These statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report.
Reclassifications
     We have reclassified amounts on the condensed consolidated statement of cash flows between other assets and prepaid expenses and other current assets to reconcile net income to net cash from operating activities for the three-month period ended March 31, 2010.
Per Share Data
     Basic and diluted income (loss) per share applicable to common stock attributable to common stockholders is computed using the weighted average number of common shares outstanding during the period. Shares used in calculating basic and diluted loss per share exclude common stock equivalents for stock-based compensation and Series A Convertible Preferred Stock, or our Preferred Stock, as these common stock equivalents are antidilutive. In future periods, if we report net income attributable to common stockholders and the common stock equivalents for our stock-based compensation and Preferred Stock are dilutive, the common stock equivalents will be included in the weighted average shares computation and dividends related to our Preferred Stock will be added back to net income attributable to common stockholders to calculate diluted earnings per share.
2. Discontinued Operations
     On November 11, 2009, BASF Corporation, or BASF, elected to terminate our Third Amended and Restated Plasticizers Production Agreement, or our Plasticizers Production Agreement, effective as of December 31, 2010. We were not subject to any early termination penalties in connection with BASF’s termination of our Plasticizers Production Agreement, although the termination of our Plasticizers Production Agreement did result in our refunding to BASF, in January 2011, a $1.0 million deposit BASF previously made to ensure prompt payment of amounts due under our Plasticizers Production Agreement. BASF, on the other hand, was required to pay us an early termination fee of $9.8 million, which we received on December 30, 2010. Under our Plasticizers Production Agreement, we were required to make payments to BASF for the undepreciated portion of past capital expenditures paid by BASF if we did not elect on or before March 31, 2011 to permanently close our plasticizers production unit. This undepreciated capital amount was determined as of the end of the original term of our Plasticizers Production Agreement, was based on a straight line, 8-year life and was estimated to be approximately $2.6 million, with approximately $1.0 million, $0.7 million, $0.6 million and $0.3 million potentially to be paid in 2011, 2012, 2013 and 2014, respectively. However, on April 4, 2011, we entered into an agreement with BASF under which we paid BASF $0.8 million in exchange for the right to make this election on or before July 10, 2011 in order to provide us with more time to determine our future plans for our plasticizers business. Under this arrangement, if we provide written notice to BASF of our election to permanently close our plasticizers production unit on or before July 10, 2011, the undepreciated capital expenditures paid by BASF for all capital projects will be deemed to be zero, and we will not be required to make any payments to BASF for undepreciated capital. However, in the event that we do not elect, on or before July 10, 2011, to permanently close our plasticizers production unit, we will be required to pay

7


Table of Contents

STERLING CHEMICALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
BASF $2.6 million, exclusive of the $0.8 million paid to BASF in April 2011, for all of the undepreciated capital on the earlier of December 31, 2011, and the date that is 30 days after we restart our plasticizers production unit.
     We are still in the process of exploring and evaluating our commercial options with respect to continuing our plasticizers business and cannot currently predict the ultimate outcome or the success of continuing our plasticizers business. As our plasticizers facility is currently idle, we have begun implementing our plans for restructuring our operating costs to reflect the reduction in our operations. On January 7, 2011, as a result of the idled state of our plasticizers facility, together with additional reductions resulting from a sustainable cost management study, we announced and subsequently implemented a reduction of our salaried work force by 22 people and our hourly work force by 16 people and recognized $1.3 million of severance costs. Additionally, as a result of the workforce reduction, we recorded a curtailment gain of $0.4 million for our benefit plans. We have incurred approximately $0.4 million in shutdown and decontamination costs during the first quarter of 2011 and expect to incur approximately $0.2 million before the end of the third quarter of 2011. The costs and timing for dismantling our plasticizers facility are unknown at this time but we do not expect these costs to be significant. The loss of our Plasticizers Production Agreement has had and will likely continue to have an adverse effect on our financial condition, results of operations and cash flows. However, due to our expected operating cash flow from our acetic acid business, our prospects for future business development projects for the site and our current cash balance, we do not believe that these effects will impact our ability to continue as a going concern. For a further description of our agreement with BASF, see “Plasticizers-BASF” under “Contracts” and “Risk Factors” in our Annual Report.
     Prior to 2008, we manufactured styrene monomer as one of our primary products. On September 17, 2007, we entered into a long-term exclusive styrene supply agreement and a related railcar purchase and sale agreement with NOVA Chemicals Inc., which was subsequently assigned by NOVA Chemicals Inc. to INEOS NOVA LLC, or INEOS NOVA. After the supply agreement became effective, INEOS NOVA nominated zero pounds of styrene under the supply agreement for the balance of 2007 and, in response, we exercised our right to terminate the supply agreement and permanently shut down our styrene facility. Under the supply agreement, we were responsible for the closure costs of our styrene facility and are also restricted from reentering the styrene business until November 2012. The restricted period was initially eight years. However, on April 1, 2008, INEOS NOVA unilaterally reduced the restricted period to five years.
     As a result of our plasticizers and styrene facilities being shut down, we do not currently have any significant continued involvement in these businesses and have, therefore, reported the operating results from these businesses as discontinued operations in our consolidated financial statements. The carrying amounts of assets and liabilities related to discontinued operations as of March 31, 2011 and December 31, 2010 are as follows:
                 
    March 31,     December 31,  
    2011     2010  
    (Dollars in Thousands)  
 
Assets of discontinued operations:
               
Accounts receivable, net
  $ 63     $ 306  
 
           
Total assets of discontinued operations
  $ 63     $ 306  
 
           
 
Liabilities of discontinued operations:
               
Liabilities of discontinued operations(1)
  $ 12,382     $ 12,382  
Long-term liabilities of discontinued operations(2)
    7,533       10,628  
 
           
Total liabilities of discontinued operations
  $ 19,915     $ 23,010  
 
           
 
(1)   Current portion of deferred income from the INEOS NOVA supply agreement that is being amortized over the contractual non-compete period of five years using the straight-line method.
 
(2)   Long-term portion of deferred income from the INEOS NOVA supply agreement that is being amortized over the contractual non-compete period of five years using the straight-line method.
     Revenues and income before income taxes from discontinued operations for the three months ended March 31, 2011 and 2010 are presented below:

8


Table of Contents

STERLING CHEMICALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
                 
    Three months ended March 31,
    2011   2010
    (Dollars in Thousands)
 
               
Revenues
  $ 3,213     $ 9,523  
Income before income taxes
    2,330       5,018  
3. Long-Term Debt
     On March 29, 2007, we completed a private offering of $150.0 million aggregate principal amount of our Secured Notes pursuant to a Purchase Agreement among us, Sterling Chemicals Energy, Inc., or Sterling Energy, one of our former wholly-owned subsidiaries, and Jefferies & Company, Inc. and CIBC World Markets Corp., as initial purchasers. In connection with that offering, we entered into an indenture dated March 29, 2007 among us, Sterling Energy, as guarantor, and U.S. Bank National Association, as trustee and collateral agent. On May 6, 2008, Sterling Energy was merged with and into us. Upon consummation of the merger, Sterling Energy no longer had independent existence and, consequently, our Secured Notes are no longer guaranteed by Sterling Energy.
     Our indenture contains affirmative and negative covenants and customary events of default, including payment defaults, breaches of covenants and certain events of bankruptcy, insolvency and reorganization. If an event of default occurs and is continuing, other than an event of default triggered upon certain bankruptcy events, the trustee under our indenture or the holders of at least 25% in principal amount of our outstanding Secured Notes may declare our Secured Notes to be due and payable immediately. Upon an event of default, the trustee may also take actions to foreclose on the collateral securing our outstanding Secured Notes. Our indenture does not require us to maintain any financial ratios or satisfy any financial maintenance tests. We are currently in compliance with all of the covenants contained in our indenture.
     Interest is due on our outstanding Secured Notes on April 1 and October 1 of each year. Our outstanding Secured Notes, which mature on April 1, 2015, are senior secured obligations and rank equally in right of payment with all of our existing and future senior indebtedness. Subject to specified permitted liens, our outstanding Secured Notes are secured (i) on a first priority basis by all of our fixed assets and certain related assets, including, without limitation, all of our property, plant and equipment and (ii) on a second priority basis by our other assets, including, without limitation, accounts receivable, inventory, capital stock of our domestic restricted subsidiaries, intellectual property, deposit accounts and investment property.
     In the first quarter of 2010, we purchased $2.0 million in aggregate principal amount of our Secured Notes, at a discount of $0.1 million, for $1.9 million in cash in the open market. The discount of $0.1 million and the $0.1 million in expense we recognized from writing off a pro rata portion of the related debt issue costs of our Secured Notes resulted in a gain of less than $0.1 million on the purchase of our Secured Notes. In the first quarter of 2011, we purchased $15.0 million in aggregate principal amount of our Secured Notes at a premium of $0.6 million, for $15.6 million in cash in the open market. The $0.6 million premium plus the $0.4 million in expense we recognized from writing off a pro rata portion of the related debt issue costs of our Secured Notes resulted in a loss of $1.0 million on the purchase of our Secured Notes.
     On December 19, 2002, we entered into a Revolving Credit Agreement, or our revolving credit facility, with The CIT Group/Business Credit, Inc. as administrative agent and a lender, and certain other lenders. Under our revolving credit facility, we and Sterling Energy were co-borrowers and were jointly and severally liable for any indebtedness thereunder. On December 10, 2009, we elected to terminate our revolving credit facility effective January 24, 2010, due to our substantial cash reserves and low working capital needs. There were no penalties or termination fees payable by us in connection with the early termination of our revolving credit facility. The remaining associated debt issue costs of $0.2 million were written off as of the effective termination date.
     On January 31, 2010, we entered into a $5.0 million Revolving Line of Credit for letters of credit, or our LC Facility, with JPMorgan Chase Bank, N.A., or Chase, for the issuance of commercial and standby letters of credit.

9


Table of Contents

STERLING CHEMICALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
Our LC Facility initially had a one year term. Under our LC Facility, we pay Chase a fee of 1% per annum of the face amount of each outstanding letter of credit and an issuance fee of $500 for each letter of credit. Since its inception, our LC Facility has been and continues to be secured by $5.0 million in cash under an Assignment of Deposit Account Agreement between us and Chase. On September 20, 2010, we amended our LC facility to extend the initial term to April 30, 2011, and concurrently therewith entered into a Security Agreement and a Pledge Agreement with Chase, pursuant to which we granted Chase first priority liens on all of our accounts receivable, inventory and other specified assets to secure our obligations under our LC Facility. Effective April 30, 2011, we extended the term of our LC facility to April 30, 2012. As of March 31, 2011, there were $3.3 million in standby letters of credit issued under our LC facility.
Debt Maturities
     Our Secured Notes, which had an aggregate outstanding principal balance of $104.4 million outstanding as of March 31, 2011, are due on April 1, 2015.
4. Commitments and Contingencies
Product Contracts:
     We have a long-term agreement which provides for the dedication of 100% of our production of acetic acid to one customer. Prior to the termination of our Plasticizers Production Agreement with BASF effective December 31, 2010, 100% of our production of plasticizers was dedicated to one customer. See Note 7 for more information.
Legal Proceedings:
     On July 5, 2005, Patrick B. McCarthy, an employee of Kinder-Morgan, Inc., or Kinder-Morgan, was seriously injured at Kinder-Morgan’s facilities near Cincinnati, Ohio, while attempting to offload a railcar containing one of our plasticizers products. On October 28, 2005, Mr. McCarthy and his family filed a suit in the Court of Common Pleas, Hamilton County, Ohio (Case No. A0509 144) against us and six other defendants. During the case, five of the other defendants were dismissed. The plaintiffs sought in excess of $42 million in alleged compensatory and punitive damages from the defendants in the aggregate. On May 7, 2009, the jury found that we had not been negligent in connection with the incident and rendered a take nothing verdict in favor of the defendants. On June 24, 2009, the plaintiffs filed a motion for judgment notwithstanding the verdict or, in the alternative, a new trial and, on September 4, 2009, the Court denied plaintiffs’ motion for judgment notwithstanding the verdict but granted plaintiffs’ motion for a new trial. We and the other remaining defendant appealed that order, as well as other orders issued during the trial. On February 25, 2011, the appeals court rendered its decision reversing the order of the trial court granting a new trial and ordering that the case be remanded to the trial court with instructions to reinstate the jury’s verdict in our favor. The plaintiffs did not appeal this ruling to the Ohio Supreme Court. After reinstatement of the jury verdict, on May 11, 2011, plaintiffs filed a second motion for a new trial. We believe that all, or substantially all, of any liability imposed upon us as a result of this suit and our related out-of-pocket costs and expenses will be covered by our insurance policies, subject to a $1.0 million deductible, which was met in January 2008. We do not believe that this incident will have a material adverse effect on our business, financial condition, results of operations or cash flows, although we cannot guarantee that a material adverse effect will not occur.
     On February 21, 2007, three retired employees of Sterling Fibers, Inc., one of our former subsidiaries, sued us, several of our benefit plans and the plan administrators for those plans in a class action suit, filed in the United States District Court, Southern District of Texas, Houston Division (Case No. H-07-0625). The plaintiffs allege that we were not permitted to increase their premiums for retiree medical insurance based on a provision contained in an asset purchase agreement between us, Sterling Fibers, Inc. and Cytec Industries Inc. and certain of its affiliates, or Cytec, that governed the purchase by Sterling Fibers, Inc. of Cytec’s acrylic fibers business in 1997. During our bankruptcy case in 2002, we and Sterling Fibers, Inc. specifically rejected this asset purchase agreement and the bankruptcy court approved that rejection. The plaintiffs claimed that we violated the terms of our benefit plans, breached fiduciary duties governed by the Employee Retirement Income Security Act and failed to comply with sections of the Bankruptcy Code dealing with retiree benefits, and sought damages, declaratory relief, punitive

10


Table of Contents

STERLING CHEMICALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
damages and attorneys’ fees. A trial for this matter was held during the second week of November 2009 and, on July 1, 2010, the judge ruled for us on the merits and dismissed all of the plaintiffs’ claims. The plaintiffs filed an appeal on July 16, 2010. Briefing for this appeal was completed in the first quarter of 2011 and we do not expect oral arguments for the appeal. We are vigorously seeking affirmation of the trial judge’s rulings. We are unable to state at this time if a loss is probable or remote and are unable to determine the possible range of loss related to this matter, if any.
     We are subject to various other claims and legal actions that arise in the ordinary course of our business. We do not believe that any of these claims and actions, separately or in the aggregate, will have a material adverse effect on our business, financial condition, results of operations or cash flows, although we cannot guarantee that a material adverse effect will not occur.
5. Income Taxes
     During the first quarter of 2011 we recorded a net tax expense of $0.5 million compared to a net tax benefit for the first quarter of 2010 of $1.2 million for income taxes from continuing operations. For the first quarter of 2010, the tax benefit from continuing operations was generated by utilizing income in discontinued operations to recognize a portion of the benefit from losses generated in continuing operations. Our continuing operations effective tax rate for the three-month period ended March 31, 2011 was 5.3% and was lower than the 35% statutory tax rate primarily due to a reduction in valuation allowances. For the three-month period ended March 31, 2010 our effective tax rate was 35%.
6. Employee Benefits
     Net periodic pension costs consisted of the following components:
                 
    Three months ended March 31,  
    2011     2010  
    (Dollars in Thousands)  
 
               
Interest cost
  $ 1,642     $ 1,745  
Expected return on plan assets
    (1,303 )     (1,160 )
Amortization
    205       191  
 
           
Net pension cost
  $ 544     $ 776  
 
           
     Other postretirement benefits consisted of the following components:
                 
    Three months ended March 31,  
    2011     2010  
    (Dollars in Thousands)  
 
               
Service cost
  $ 7     $ 10  
Interest cost
    80       95  
Prior service costs
    (544 )     (544 )
Curtailment gain
    (374 )     (115 )
 
           
Net plan benefit
  $ (831 )   $ (554 )
 
           
     During the first quarter of 2011 and 2010, we announced and completed reductions in our work force and as a result we recorded a curtailment gain of $0.4 million and $0.1 million, respectively, under our retiree medical plans.
     Total pension contributions of $6.1 million were paid during the first quarter of 2011. We do not expect to pay any further pension contributions in 2011.

11


Table of Contents

STERLING CHEMICALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
7. Operating Segment and Sales Information
     Historically, we reported our operations through two segments: acetic acid and plasticizers. Effective December 31, 2010, our Plasticizers Production Agreement with BASF was terminated by BASF and we discontinued production of plasticizers for BASF. As a result, we have reported plasticizers for 2011 and 2010 in discontinued operations and, as such, the financial statement information provided in this report for continuing operations for the quarters ended March 31, 2011 and 2010 are presented in one reportable segment. Primarily all of our revenues and outstanding trade receivables in continuing operations are attributable to one customer.
8. Fair Value Measurements
Fair Value of Financial Instruments
     The fair value of our financial instruments has been estimated in accordance with GAAP. The fair value of our fixed rate long-term debt is estimated based on quoted market prices or prices quoted from third-party financial institutions. The carrying and fair values of our long-term debt are as follows:
                                 
    March 31, 2011   December 31, 2010
    Carrying           Carrying    
    Value   Fair Value   Value   Fair Value
10.25% senior secured notes due April 2015
  $ 104,428     $ 108,605     $ 119,428     $ 123,011  
The fair values of our cash equivalents, trade receivables and trade payables approximate their carrying values due to the short-term nature of these instruments.
Nonrecurring Fair Value Measurements
     Effective January 1, 2009, fair value measurements were applied with respect to our non-financial assets and liabilities. We measure certain non-financial assets and liabilities, including long-lived assets, at fair value on a non-recurring basis. The fair market value of these assets is determined using Level 3 inputs, which requires management to make estimates about future cash flows. Management estimates the amount and timing of future cash flows based on its experience and knowledge of market factors.
9. New Accounting Standards
Adoption of Accounting Standards:
     In January 2010, the Financial Accounting Standards Board issued Accounting Standards Update No. 2010-06, an amendment to ASC Topic 820-10, “Fair Value Measurements and Disclosures (Topic 820): Improving Disclosures about Fair Value Measurements,” or ASU No. 2010-06. ASU No. 2010-06 requires new disclosures and clarifies some existing disclosure requirements with respect to fair value measurement as set forth in Codification Subtopic 820-10. The objective of ASU No. 2010-06 is to improve these disclosures and increase the transparency in financial reporting. Specifically, ASU No. 2010-06 amends ASC Topic 820-10 to require that:
    a reporting entity disclose separately the amounts of significant transfers in and out of Level 1 and Level 2 fair value measurements and the reasons for the transfers; and
    a reporting entity present separately information about purchases, sales, issuances and settlements in the reconciliation for fair value measurements using significant unobservable inputs.
In addition, ASU No. 2010-06 provides that:
    for purposes of reporting fair value measurements for each class of assets and liabilities, a reporting entity needs to use judgment in determining the appropriate classes of assets and liabilities; and

12


Table of Contents

STERLING CHEMICALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
    a reporting entity should provide disclosures about the valuation techniques and inputs used to measure fair value for both recurring and nonrecurring fair value measurements.
ASU No. 2010-06 is effective for interim and annual reporting periods beginning after December 15, 2009, except for the disclosures with respect to purchases, sales, issuances and settlements in the roll forward of activity in Level 3 fair value measurements. Those disclosures are effective for fiscal years beginning after December 15, 2010, and for interim periods within those fiscal years. Early application is permitted. We implemented ASU No. 2010-06 effective January 1, 2010, and have enhanced our disclosures to comply with ASU No. 2010-06.

13


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
     The following discussion should be read in conjunction with our condensed consolidated financial statements (including the Notes thereto) included in Item 1, Part I of this report.
Business Overview
     We are a Delaware Corporation formed in 1986 to acquire a petrochemicals manufacturing facility located in Texas City, Texas, or our Texas City facility, that was previously owned by Monsanto Company. We are a producer of select petrochemicals used to manufacture a wide array of consumer goods and industrial products. Until 2011, our primary products included acetic acid and plasticizers. All of our plasticizers were historically produced for BASF Corporation, or BASF, pursuant to the terms of our Third Amended and Restated Plasticizers Production Agreement, or our Plasticizers Production Agreement. However, on November 11, 2009, BASF elected to terminate our Plasticizers Production Agreement effective as of December 31, 2010. As our plasticizers facility is currently idle, acetic acid is currently our only primary product.
     Our Texas City facility is strategically located on Galveston Bay and benefits from a deep-water dock capable of handling ships with up to a 40-foot draft, as well as four barge docks and direct access to the Union Pacific and Burlington Northern Santa Fe railways with in-motion rail scales on site. Our Texas City facility also has truck loading racks, weigh scales, stainless and carbon steel storage tanks, 160 acres of available land zoned for heavy industrial use, 30 acres of additional land zoned for light industrial use and a supportive political environment for growth. Prior to the sale of 150 tons of perpetual nitrogen oxide, or NOx, allowances under the Texas Commission on Environmental Quality, or TCEQ, Mass Emissions Cap and Trade Program which apply to the eight county Houston-Galveston-Brazoria, Texas nonattainment area for $12.8 million, we had 240 excess tons available to be sold or used for development projects. We presently have 90 excess tons which could be sold or used for development projects. We are in the heart of one of the largest petrochemical complexes on the Gulf Coast and, as a result, have on-site access to a number of raw material pipelines, as well as close proximity to a number of large refinery complexes. Given our under-utilized infrastructure and our management, operational and engineering expertise, as well as our ample unoccupied land, we believe that there are significant opportunities for further development of our Texas City facility. We are currently pursuing numerous initiatives to attract new manufacturing, distribution or storage related businesses. Specifically, we are seeking long-term contractual business arrangements or partnerships that will provide us with an ability to realize the value of our under-utilized assets through profit sharing, operating fees or other revenue generating arrangements. For development projects that may have significant capital expenditure requirements, we are considering joint ventures or other arrangements where we would contribute certain of our assets, management and operational expertise to minimize our share of the capital costs. In any case, we expect any new facility constructed at our Texas City facility to lower the amount of overall fixed costs allocated to our operating unit and provide us with additional profit. In the third quarter of 2010, we entered into a contract involving the terminaling of methanol as a part of our strategy which we expect to begin producing revenues in the third quarter of 2011, although we do not expect this transaction to have a material affect on our business, financial results or cash flows. Similarly, in the first quarter of 2011, we entered into a contract involving the terminaling of crude oil as a part of our strategy. In accordance with the contract terms, we received a payment of $0.5 million in April related to the lease and easement rights granted to the third party. We expect to begin generating operating revenues in the first quarter of 2012, although we do not expect this transaction to have a material affect on our business, financial results or cash flows.
     The acetic acid we produce is used primarily to manufacture vinyl acetate monomer which is used in a variety of products related to construction materials and automotive parts, such as adhesives, surface coatings, polyester fibers and films, and to manufacture purified terephthalic acid, which is used to produce plastic bottle resins. Pursuant to our 2008 Amended and Restated Acetic Acid Production Agreement, or our Acetic Acid Production Agreement, that extends through 2031, BP Amoco Chemical Company, or BP Chemicals, takes title and risk of loss to our acetic acid production at the time the acetic acid is produced. We entered into the initial version of our Acetic Acid Production Agreement with BP Chemicals in 1986, which has since been amended several times. We are BP Chemicals’ sole source of acetic acid production in the Americas. BP Chemicals markets all of the acetic acid that we produce and pays us, among other amounts, a portion of the profits derived from its sales of the acetic acid we produce. In addition, BP Chemicals reimburses us for 100% of our fixed and variable costs of production, other than specified

14


Table of Contents

indirect costs. We also jointly invest with BP Chemicals in capital expenditures related to our acetic acid facility in the same percentage as the portion of the profits we receive from BP Chemicals.
     Our rated annual production capacity for acetic acid is among the highest in North America. In mid-2009, we and BP Chemicals implemented an incremental expansion of our acetic acid plant to 1.3 billion pounds of annual capacity, which represents approximately 20% of total North American capacity, making our acetic acid facility the second largest acetic acid production facility in North America. Our acetic acid facility utilizes BP Chemicals’ proprietary “Cativa” methanol carbonylation technology, which we believe offers several advantages over competing production methods, including lower energy requirements and lower fixed and variable costs. Acetic acid production has two major raw material requirements, methanol and carbon monoxide. BP Chemicals, a producer of methanol, supplies 100% of our methanol requirements related to our production of acetic acid. All of our requirements for carbon monoxide are supplied by Praxair Hydrogen Supply, Inc., or Praxair, from a partial oxidation unit constructed by Praxair on land leased from us at our Texas City facility.
     Previously, our plasticizers business was comprised of two separate products: phthalate esters and phthalic anhydride, or PA, together commonly referred to as plasticizers. The types of plasticizers we produced are used to make flexible plastics, such as shower curtains, floor coverings, automotive parts and construction materials. Since our formation in 1986, we produced plasticizers exclusively for BASF pursuant to our Plasticizers Production Agreement, which was amended several times. Under our Plasticizers Production Agreement, BASF provided us with most of the required raw materials, marketed the plasticizers that we produced, made certain fixed quarterly payments to us and reimbursed us monthly for our actual production costs and capital expenditures related to our plasticizers facility.
     On November 11, 2009, BASF elected to terminate our Plasticizers Production Agreement, effective as of December 31, 2010. We were not subject to any early termination penalties in connection with BASF’s termination of our Plasticizers Production Agreement, although the termination of our Plasticizers Production Agreement did result in our refunding to BASF, in January 2011, a $1.0 million deposit BASF previously made to ensure prompt payment of amounts due under our Plasticizers Production Agreement. BASF, on the other hand, was required to pay us an early termination fee of $9.8 million, which we received on December 30, 2010. Under our Plasticizers Production Agreement, we were required to make payments to BASF for the undepreciated portion of past capital expenditures paid by BASF if we did not elect on or before March 31, 2011 to permanently close our plasticizers production unit. This undepreciated capital amount was determined as of the end of the original term of our Plasticizers Production Agreement, was based on a straight line, 8-year life and was estimated to be approximately $2.6 million, with approximately $1.0 million, $0.7 million, $0.6 million and $0.3 million potentially to be paid in 2011, 2012, 2013 and 2014, respectively. However, on April 4, 2011, we entered into an agreement with BASF under which we paid BASF $0.8 million in exchange for the right to make this election on or before July 10, 2011 in order to provide us with more time to determine our future plans for our plasticizers business. Under this arrangement, if we provide written notice to BASF of our election to permanently close our plasticizers production unit on or before July 10, 2011, the undepreciated capital expenditures paid by BASF for all capital projects will be deemed to be zero, and we will not be required to make any payments to BASF for undepreciated capital. However, in the event that we do not elect on or before July 10, 2011 to permanently close our plasticizers production unit, we will be required to pay BASF $2.6 million, exclusive of the $0.8 million paid to BASF in April 2011, for all of the undepreciated capital on the earlier of December 31, 2011, and the date that is 30 days after we restart our plasticizers production unit.
     We are still in the process of exploring and evaluating our commercial options with respect to continuing our plasticizers business and cannot currently predict the ultimate outcome or the success of continuing our plasticizers business. As our plasticizers facility is currently idle, we have begun implementing our plans for restructuring our operating costs to reflect the reduction in our operations. On January 7, 2011, as a result of the idled state of our plasticizers facility, together with additional reductions resulting from a sustainable cost management study, we announced and subsequently implemented a reduction of our salaried work force by 22 people and our hourly work force by 16 people and recognized $1.3 million of severance costs. Additionally, as a result of the workforce reduction, we recorded a curtailment gain of $0.4 million for our benefit plans. We have incurred approximately $0.4 million in shutdown and decontamination costs during the first quarter of 2011 and expect to incur approximately $0.2 million during the third quarter of 2011. The costs and timing for dismantling our plasticizers facility are

15


Table of Contents

unknown at this time but we do not expect these costs to be significant. The loss of our Plasticizers Production Agreement has had and will likely continue to have an adverse effect on our financial condition, results of operations and cash flows. However, due to our expected operating cash flow from our acetic acid business, our prospects for future business development projects for the site and our current cash balance, we do not believe that these effects will impact our ability to continue as a going concern. For a further description of our agreement with BASF, see “Plasticizers-BASF” under “Contracts” and “Risk Factors” in our Annual Report.
Recent Developments
     On March 14, 2011, we sold 150 tons of our perpetual NOx allowances for $12.8 million. These NOx allowances are under the TCEQ Mass Emissions Cap and Trade Program and apply to the eight county Houston-Galveston-Brazoria, Texas nonattainment area. As a result of the sale of 150 tons of our perpetual NOx allowances, we now have approximately 90 excess tons of perpetual NOx allowances that are available for sale or to be used in our development projects.
     On March 24, 2011 we entered into a contract involving the terminaling of crude oil at our Texas City facility. The agreement involves the use of three of our storage tanks and one of our barge docks. In accordance with the contract terms, in April 2011 we received a payment of $0.5 million for the lease and easement rights granted to the third party, which will be recognized as income in the second quarter of 2011. We expect to begin generating operating revenues in the first quarter of 2012.
Results of Operations
The following table sets forth key information about our financial results:
                 
    Three months ended March 31,
    2011   2010
    (Dollars in Thousands)
 
               
Revenues
  $ 25,951     $ 26,682  
Cost of goods sold
    22,822       23,522  
Gross profit
    3,129       3,160  
Selling, general and administrative expenses
    3,047       2,894  
Impairment of long-lived assets
          290  
Interest and debt related expenses
    3,126       3,607  
Interest income
    (92 )     (49 )
Other income
    (12,802 )     (76 )
Income tax expense (benefit)
    519       (1,227 )
Income (loss) from continuing operations
    9,331       (2,279 )
Income from discontinued operations, net of tax expense of zero and $1,756, respectively
    2,330       3,262  
Three Months Ended March 31, 2011 Compared to Three Months Ended March 31, 2010
     Revenues and gross profit
     Our revenues from continuing operations decreased by $0.7 million, or 3%, in the first quarter of 2011 compared to the first quarter of 2010. This decrease was due to a $1.9 million decrease in cost reimbursements under our Acetic Acid Production Agreement, primarily due to lower natural gas prices in the first quarter of 2011 compared to the first quarter of 2010. This decrease was partially offset by a $0.4 million increase in revenue resulting from higher contribution margins for our acetic acid operations in the first quarter of 2011 compared to the first quarter of 2010 and the sale of our ammonia inventory for $0.8 million in the first quarter of 2011.

16


Table of Contents

     Our gross profit from continuing operations decreased less than $0.1 million, or less than 1%, in the first quarter of 2011 compared to the first quarter of 2010. This decrease in gross profit was primarily due to $1.3 million of expense in the first quarter of 2011 related to our methanol terminaling project, partially offset by a $0.6 million increase in gross profit from our ammonia terminaling operations resulting from the gain on sale of our ammonia inventory to Ascend of $0.5 million, and a $0.4 million increase in revenue due to higher contribution margins from our acetic acid operations.
     Impairment of long-lived assets
     We did not recognize any impairments during the first quarter of 2011. The impairment we recorded in the first quarter of 2010 consisted of a $0.3 million impairment charge to reduce the carrying value of one of our turbo generator units, which we have classified as a spare, to its net realizable value.
     Interest and debt related expenses
     Our interest and debt related expenses decreased by $0.5 million, or 13%, in the first quarter of 2011 compared to the first quarter of 2010. This decrease was primarily due to interest savings of $0.2 million arising out of our purchase of $45.6 million in aggregate principal amount of our 10-1/4% Senior Secured Notes due 2015, or our Secured Notes, over the period November 2009 through March 2011. In addition, we wrote off $0.2 million of debt issue costs associated with the termination of our Revolving Credit Agreement, or our revolving credit facility, with The CIT Group/Business Credit, Inc., as administrative agent and a lender, and certain other lenders, as of January 2010, the effective termination date of our revolving credit facility.
     Other income
     Other income increased by $12.7 million, or greater than 100%, in the first quarter of 2011 compared to the first quarter of 2010. This increase was primarily due to the sale of 150 tons of our perpetual NOx allowances for $12.8 million, offset by broker’s fees of $0.4 million, and $1.3 million of increased insurance proceeds, both in the first quarter of 2011. This increase was partially offset by a $1.0 million loss on debt extinguishment in the first quarter of 2011.
     Income tax expense (benefit)
     During the first quarter of 2011, we recorded a net tax expense of $0.5 million compared to a net tax benefit for the first quarter of 2010 of $1.2 million for income taxes from continuing operations. For the first quarter of 2010, the tax benefit from continuing operations was generated by utilizing income in discontinued operations to recognize a portion of the benefit from losses generated in continuing operations. For the three-month periods ended March 31, 2011 and March 31, 2010, our continuing operations effective tax rate was 5.3% and 35%, respectively.
     Income from discontinued operations, net of tax
     Income from our discontinued operations, net of tax, decreased $0.9 million, or 29%, in the first quarter of 2011 compared to the first quarter of 2010. This decrease was primarily due to the closure of our plasticizers business on December 31, 2010, which had been in operation during the first quarter of 2010 and contributed $2.0 million of gross profit to discontinued operations partially offset by $1.8 million of related tax expense, compared to the incurrence of approximately $0.4 million in decontamination costs and $0.5 million of severance in the first quarter of 2011, resulting in a $0.8 million loss during the first quarter of 2011.
Liquidity and Capital Resources
General
     Our working capital was $99.8 million as of March 31, 2011, a decrease of $7.9 million from our working capital of $107.7 million as of December 31, 2010. This decrease was primarily due to the purchase of $15.0 million in aggregate principal amount of our Secured Notes for $15.6 million, a $0.8 million decrease in prepaid

17


Table of Contents

insurance due to expense recognition, a $3.0 million increase in accrued interest, capital expenditures of $2.3 million, $1.3 million in severance payments, a $1.4 million reclassification from long-term pension liability to short-term pension liability, $1.3 million in cost related to our methanol project, a $1.3 million reclassification from long-term incentive plan liability to current portion of long-term incentive plan liability, a $0.5 million accrual for variable compensation, a $0.5 million accrual for state income tax, $0.3 million in net benefit payments and a property tax accrual of $0.3 million. Partially offsetting this decrease was an increase in cash for a $1.1 million insurance reimbursement and the sale of 150 tons of our perpetual NOx allowances for $12.8 million, offset by broker’s fees of $0.4 million and a $6.6 million accrual for profit sharing revenue.
     Our liquidity was $106.1 million as of March 31, 2011, a decrease of $24.2 million from our liquidity of $130.3 million as of December 31, 2010. This decrease was primarily due to the $6.1 million pension contribution we made in the first quarter of 2011, capital expenditures of $2.3 million, and our purchase of $15.0 million in aggregate principal amount of our Secured Notes in 2010 for $15.6 million. We periodically review the balance of our cash on hand in light of our strategic objectives and the restrictions on the use of cash contained in the indenture for our Secured Notes. As opportunities arise, we intend to utilize our cash as circumstances warrant, possibly in material amounts, to fund all or a portion of the purchase price of mergers or acquisitions, engage in project development work, make contributions to our defined benefit plans or purchase our outstanding Secured Notes on the open market, in privately negotiated transactions, or otherwise.
     On November 11, 2009, BASF elected to terminate our Plasticizers Production Agreement, effective as of December 31, 2010. Revenues and gross profit generated from our plasticizers operations in the first quarter of 2010 were $6.4 million and $2.0 million, respectively. The termination of our Plasticizers Production Agreement has had and will likely continue to have an adverse effect on our liquidity. However, we believe that our expected operating cash flow from our acetic acid business and our current cash balance will provide adequate liquidity for the foreseeable future.
     We invest our excess cash in various investments. Our cash is invested in money market funds and certificates of deposit. However, we may invest cash in other high quality, highly liquid cash equivalents from time to time.
Debt
     On March 29, 2007, we completed a private offering of $150.0 million aggregate principal amount of Secured Notes pursuant to a Purchase Agreement among us, Sterling Chemicals Energy, Inc., or Sterling Energy, one of our former wholly-owned subsidiaries, and Jefferies & Company, Inc. and CIBC World Markets Corp., as initial purchasers. In connection with that offering, we entered into an indenture dated March 29, 2007 among us, Sterling Energy, as guarantor, and U.S. Bank National Association, as trustee and collateral agent. On May 6, 2008, Sterling Energy was merged with and into us. Upon consummation of the merger, Sterling Energy no longer had independent existence and, consequently, our Secured Notes are no longer guaranteed by Sterling Energy.
     Our indenture contains affirmative and negative covenants and customary events of default, including payment defaults, breaches of covenants and certain events of bankruptcy, insolvency and reorganization. If an event of default occurs and is continuing, other than an event of default triggered upon certain bankruptcy events, the trustee under our indenture or the holders of at least 25% in principal amount of our outstanding Secured Notes may declare our Secured Notes to be due and payable immediately. Upon an event of default, the trustee may also take actions to foreclose on the collateral securing our outstanding Secured Notes. Our indenture does not require us to maintain any financial ratios or satisfy any financial maintenance tests. We are currently in compliance with all of the covenants contained in our indenture.
     Interest is due on our outstanding Secured Notes on April 1 and October 1 of each year. Our outstanding Secured Notes, which mature on April 1, 2015, are senior secured obligations and rank equally in right of payment with all of our existing and future senior indebtedness. Subject to specified permitted liens, our outstanding Secured Notes are secured (i) on a first priority basis by all of our fixed assets and certain related assets, including, without limitation, all of our property, plant and equipment and (ii) on a second priority basis by our other assets, including, without limitation, accounts receivable, inventory, capital stock of our domestic restricted subsidiaries, intellectual property, deposit accounts and investment property.

18


Table of Contents

     In the first quarter of 2010, we purchased $2.0 million in aggregate principal amount of our Secured Notes, at a discount of $0.1 million, for $1.9 million in cash in the open market. The discount of $0.1 million and the $0.1 million in expense we recognized from writing off a pro rata portion of the related debt issue costs of our Secured Notes resulted in a gain of less than $0.1 million on the purchase of our Secured Notes. In the first quarter of 2011, we purchased $15.0 million in aggregate principal amount of our Secured Notes at a premium of $0.6 million, for $15.6 million in cash in the open market. The $0.6 million premium plus the $0.4 million in expense we recognized from writing off a pro rata portion of the related debt issue costs of our Secured Notes resulted in a loss of $1.0 million on the purchase of our Secured Notes.
     On December 19, 2002, we entered into our revolving credit facility. Under our revolving credit facility, we and Sterling Energy were co-borrowers and were jointly and severally liable for any indebtedness thereunder. On December 10, 2009, we elected to terminate our revolving credit facility effective January 24, 2010, due to our substantial cash reserves and low working capital needs. There were no penalties or termination fees payable by us in connection with the early termination of our revolving credit facility. The remaining associated debt issue costs of $0.2 million were written off as of the effective termination date.
     On January 31, 2010, we entered into a $5.0 million Revolving Line of Credit for letters of credit, or our LC Facility, with JPMorgan Chase Bank, N.A., or Chase, for the issuance of commercial and standby letters of credit. Our LC Facility initially had a one year term. Under our LC Facility, we pay Chase a fee of 1% per annum of the face amount of each outstanding letter of credit and an issuance fee of $500 for each letter of credit. Since its inception, our LC Facility has been and continues to be secured by $5.0 million in cash under an Assignment of Deposit Account Agreement between us and Chase. On September 20, 2010, we amended our LC facility to extend the initial term to April 30, 2011, and concurrently therewith entered into a Security Agreement and a Pledge Agreement with Chase, pursuant to which we granted Chase first priority liens on all of our accounts receivable, inventory and other specified assets to secure our obligations under our LC Facility. Effective April 30, 2011, we extended the term of our LC facility to April 30, 2012. As of March 31, 2011, there were $3.3 million in standby letters of credit issued under our LC facility.
     We continuously evaluate various transactions to enhance stakeholder value as opportunities arise. As part of our strategic goals, we are seeking to consummate strategic transactions, including, but not limited to, acquisitions of assets or businesses and the formation of joint ventures or other business combinations and other strategic alternatives. Although we do not currently have any commitments with respect to any strategic transactions, we may enter into such commitments in the future, which could, among other things, result in a material expansion of our existing operations or result in our entering into new lines of business. In addition, a strategic transaction could, among other things, result in the expenditure of a material amount of our funds or the issuance by us of a material amount of debt or equity securities. There can be no assurance that we will pursue any particular transaction or that any such transaction will be successful. See “Business Strategy” under “Business” in our Annual Report.
Cash Flow
     Net cash used in operations was $6.7 million during the first three months of 2011, a greater than 100% increase from the $0.1 million in net cash used in operations during the first three months of 2010. This increase in net cash used in operations was primarily due to a $6.1 million pension contribution made in the first quarter of 2011. Net cash provided by investing activities was $7.1 million during the first three months of 2011, a greater than 100% increase from the $0.6 million net cash used in investing activities during the first three months of 2010. This increase in net cash provided by investing activities was primarily due to the redemption of a short-term investment of $9.0 million in the first quarter of 2011 partially offset by higher capital expenditures of $1.7 million in the first quarter of 2011 primarily for our methanol terminaling project. Net cash used in financing activities was $15.6 million during the first three months of 2011 and $1.9 million during the first three months of 2010. This increase in net cash flow used in financing activities was primarily due to our purchase of $15.0 million in aggregate principal amount of our Secured Notes for $15.6 million in the first quarter of 2011 compared to our purchase of $2.0 million in aggregate principal amount of our Secured Notes for $1.9 million in the first quarter of 2010.
Critical Accounting Policies, Use of Estimates and Assumptions

19


Table of Contents

     The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and related notes. Actual results could differ from those estimates. On an ongoing basis, we review our estimates, including those related to the allowance for doubtful accounts, recoverability of long-lived assets, deferred tax asset valuation allowance, litigation, environmental liabilities, pension and post-retirement benefits, preferred stock dividends and various other operating allowances and accruals, based on currently available information. Changes in facts and circumstances may alter such estimates and affect our results of operations and financial position in future periods. There have been no material changes or developments in our evaluation of the accounting estimates or the underlying assumptions or methodologies that we believe to be critical accounting policies disclosed in our Annual Report.
Item 4. Controls and Procedures
     Evaluation of Disclosure Controls and Procedures. We maintain disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) designed to provide reasonable assurance that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. These include controls and procedures designed to ensure that this information is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Because of its inherent limitations, internal controls over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives.
     Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2011. Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of March 31, 2011.
     We believe that our financial statements contained in this Form 10-Q accurately present our financial condition, results of operations and cash flows in all material respects.
     Changes in Internal Controls over Financial Reporting. There have been no changes in our internal controls over financial reporting for the quarter ended March 31, 2011 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.
PART II.
OTHER INFORMATION
Item 1. Legal Proceedings
     The information under “Legal Proceedings” in Note 4 to the condensed consolidated financial statements included in Item 1 of Part I of this report is hereby incorporated by reference.
Item 6. Exhibits
     Exhibits not incorporated by reference to a prior filing and filed or furnished herewith are designated by an “*.” All exhibits not so designated are incorporated herein by reference to a prior filing as indicated.
         
Exhibit        
Number       Description of Exhibit
 
       
10.1
    Amended and Restated $5,000,000 Revolving Line of Credit for letters of credit from JPMorgan Chase Bank, N.A. to Sterling Chemicals, Inc.
 
       
15.1
    Letter of Grant Thornton LLP regarding unaudited interim financial information.
 
       
31.1
    Rule 13a-14(a) Certification of the Chief Executive Officer.

20


Table of Contents

         
Exhibit        
Number       Description of Exhibit
 
       
31.2
    Rule 13a-14(a) Certification of the Principal Financial Officer.
 
       
32.1
    Section 1350 Certification of the Chief Executive Officer.
 
       
32.2
    Section 1350 Certification of the Principal Financial Officer.

21


Table of Contents

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
         
  STERLING CHEMICALS, INC.
(Registrant)
 
 
Date: May 13, 2011  By   /s/ JOHN V. GENOVA    
    John V. Genova   
    President and Chief Executive Officer   
 
     
Date: May 13, 2011  By   /s/ DAVID J. COLLINS    
    David J. Collins   
    Senior Vice President and Chief Financial Officer (Principal Financial Officer)   

22


Table of Contents

EXHIBIT INDEX
         
Exhibit        
Number       Description of Exhibit
 
       
*10.1
    Amended and Restated $5,000,000 Revolving Line of Credit for letters of credit from JPMorgan Chase Bank, N.A. to Sterling Chemicals, Inc.
 
       
*15.1
    Letter of Grant Thornton LLP regarding unaudited interim financial information.
 
       
*31.1
    Rule 13a-14(a) Certification of the Chief Executive Officer.
 
       
*31.2
    Rule 13a-14(a) Certification of the Principal Financial Officer.
 
       
*32.1
    Section 1350 Certification of the Chief Executive Officer.
 
       
*32.2
    Section 1350 Certification of the Principal Financial Officer.
 
*   Filed or furnished herewith

23